PPTA Twitter

PlasmaProteins #Plasma goes through a complex manufacturing process known as fractionation where proteins are separated to develop #plasmaprotein therapies. Learn more about the process: bit.ly/2ytTQCI pic.twitter.com/ZYK7nzwrvi

1 day ago.

PlasmaProteins Next month, @PlasmaProteins will hold its annual Fly-In on Capitol Hill! PPTA, its membership, and stakeholders will advocate for patient protections & the importance of prohibitions on lifetime and annual caps for people who need #plasmaprotein therapies. bit.ly/2FRKqnR

2 days ago.

Restrictive Coverage Policies and Patient Access

Please read this timely article by Mark Ballow, M.D. published in Healthcare Payer News. Dr. Ballow addresses restrictive coverage policies that have a negative impact on patient access and patient care; particularly focusing on patients with primary immunodeficiency diseases.

PPTA News

IQPP Standards Public Review Period Now Open! +
The following draft has been issued for public review:
- Version 4.0 of the IQPP Qualified Donor Standard
In accordance with the procedures for developing PPTA Voluntary Standards, this document is hereby issued for public review, from April 18, 2019 until June 16, 2019. This is a proposed revision to Version 4.0.
Read More
IQPP Standards Public Review Period Now Open! +

The following draft has been issued for public review:

Public Review Draft 1, Proposed Revision to Version 4.0 of the IQPP Quality Assurance Standard
Read More
Register now for the 2019 Plasma Protein Forum! +

The 2019 Plasma Protein Forum will be held Tuesday, June 18 - Wednesday, June 19 at the Hyatt Regency Reston in Reston, Virginia, U.S.

Online registration closes
June 14--Register now!
Read More